Pulse and Regional Oximeters Improving Treatment of Targeted Diseases

The World Health Organization (WHO) is dedicated toward generating awareness regarding pulse and regional oximeters among caregivers, as these products help in reducing anesthetic mortality by a considerable margin. The safe surgical checklist of the WHO includes pulse and regional oximeters as standard of operation (SOP). In the same lines, the Indian Society of Anesthesiologists (ISA) also conducted numerous conferences to boost the adoption of these devices in healthcare facilities. Moreover, the ISA also declared such medical products as a part to first-aid to detect hypoxia and prevent inadequate ventilation.

Browse In-depth Pulse and Regional Oximeters Market Growth Forecast Research Report

Healthcare facilities across the world are increasingly adopting pulse and regional oximeters to deal with the surging cases of targeted diseases. These devices are used in several healthcare units to evaluate the oxygenation status of patients. They are required for patients suffering from sickle-cell crisis, cardiac arrest, apneic condition, and multisystem trauma. The wide application of these devices will accelerate the pulse and regional oximeters market at 8.2% CAGR during 2019–2024. The market stood at $2,101.0 million in 2018 and it is expected to reach $3,365.0 million by 2024.

Currently, market players are acquiring other companies to develop advanced and innovative devices, which are being used to treat cardiovascular diseases (CVDs), respiratory ailments, and neurological disorders. For example, Edwards Lifesciences Corporation completed the acquisition of CAS Medical Systems Inc. (CASMED) in April 2019 to pair its HemoSphere advanced hemodynamic monitoring platform with the FORE-SIGHT non-invasive cerebral oxygenation technology of CASMED. This assembly helps in creating improved predictive analytics capabilities and recovery tools for clinics.

According to P&S Intelligence, North America will dominate the pulse and regional oximeters market in the near future, globally. This can be ascribed to the vast geriatric population, advanced healthcare system, and presence of established players. Additionally, the growing prevalence of targeted diseases will also amplify the requirement for pulse and regional oximeters in the coming years. Whereas, the Asia-Pacific (APAC) market is expected to display the fastest growth, mainly on account of improving healthcare infrastructure and mounting focus of players on expanding their businesses in emerging economies like India and China.

Thus, the strengthening of health regulations from the national and international bodies along with vast number of chronic disease patients will fuel the need for pulse and regional oximeters in the coming years.